18F-Florbetaben

DRUG6 trials

Sponsors

Patrick Lao, Adam Brickman, National Institute of Mental Health (NIMH), Columbia University

Conditions

ALSAlzheimer DiseaseAlzheimer s DiseaseAlzheimer's DiseaseDementiaHealthyMild Cognitive ImpairmentParkinson's Disease

Phase 1

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

CompletedNCT03706261

Adam BrickmanAlzheimer Disease

Start: 2019-03-22End: 2023-07-14Updated: 2025-08-01

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

RecruitingNCT04396873

National Institute of Mental Health (NIMH)ALS, Alzheimer's Disease, Dementia +2

Start: 2021-08-17End: 2030-10-03Target: 184Updated: 2026-02-17

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

RecruitingNCT07169630

National Institute of Mental Health (NIMH)Alzheimer s Disease, Healthy, Mild Cognitive Impairment

Start: 2026-04-08End: 2030-04-11Target: 90Updated: 2026-04-03

Phase 2

Imaging Inflammation in Alzheimer's Disease

CompletedNCT02831283

Patrick LaoAlzheimer's Disease

Start: 2016-06-30End: 2022-12-31Updated: 2025-03-05

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

RecruitingNCT04576793

Patrick LaoAlzheimer Disease

Start: 2020-11-17End: 2026-05-31Target: 100Updated: 2025-07-03

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

RecruitingNCT04840979

Columbia UniversityAlzheimer Disease

Start: 2021-05-11End: 2026-12-31Target: 250Updated: 2025-04-24

Related Papers

Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer’s Disease

Journal of Alzheimer s Disease2021-02-2051 citations